• Rentschler Biopharma Names Martin Kessler as New CEO in U.S. contractpharma
    April 01, 2021
    Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed of Dr. Martin Kessler as CEO of Rentschler Biopharma Inc., the company’s wholly owned U.S. subsidiary, and as ...
PharmaSources Customer Service